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Dissection of the G immunoglobulin molecules in man, using enzymic (1, 2) as well 
as chemical techniques (3, 4), has proceeded more rapidly than similar studies of the 
other two classes of Ig's and has provided a great deal of insight into the nature of 
the structural units and their genetic control. Using starch gel electrophoresis (3, 5) 
immunologic techniques (6, 7), and peptide analyses (8), it has been possible to demon- 
strate differences in light chains of different myeloma proteins, Bence Jones proteins, 
and  antibodies.  Similar  techniques  have also  demonstrated  differences  in  electro- 
phoretic mobilities of the heavy chains  of different myeloma proteins (5, 9), Except 
for a report showing  that differences in the mobilifies  of myeloma proteins correlate 
with the properties of the Fd fragments (9), little is known about the exact nature of 
these variations or their possible significance. A precise delineation  of these differences 
has been hampered by difficulties in obtaining the Fd fragment (A piece), free of light 
chains or the Fc (fast) fragment. 
One approach to this question,  which  obviates the necessity of isolating the Fd 
fragment, is to determine its composition by comparing the peptide analyses (finger- 
prints)  of the heavy chains  and the Fc papain fragments from individual myeloma 
proteins or normal IgG fractions. Further information dealing with structural differ- 
ences between different myeloma proteins, and differences between myeloma proteins 
and normal G  immunoglobulins can be obtained by comparing the fragments and 
chains from different myeloma proteins to  each other and  to  those obtained from 
normal G immunoglobulins.  Since the Fd fragment (10) consists  of that part of the 
heavy chain not present in the Fc fragment, it is possible to recognize  the peptides 
belonging to the Fd fragment without actually having to isolate it by comparing the 
maps of these two readily available, well defined  structural units. 
The  studies  reported  here  have  demonstrated  a  striking  similarity in  the 
peptide maps of the Fc fragments of a large number of normal and pathologic 
G  immunoglobulins  belonging  to  the  We  (b)  antigenic  subtype of "},-chains. 
Similarities  were  also  noted  among  Fc  fragments  prepared  from  a  smaller 
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number of Vi (c) type of myeloma proteins.  The major variations within each 
subtype were those related to differences in the Gm type previously  reported 
(13); a few additional minor differences were occasionally noted, but these were 
generally absent from the heavy chains of the same protein.  In contrast, the 
heavy chains from different  G myeloma proteins,  presumably by virtue of the 
Fd  fragment,  showed  a  great  deal  of variability and,  generally,  contained 
several spots not seen in the corresponding heavy chains from normal subjects. 
This finding, together with the observation  that normal heavy chains contain 
a greater amount of faint background staining and fewer distinct well defined 
peptides than expected on the basis of arginine and lysine content, and also a 
smaller number than heavy chains prepared from individual myeloma proteins, 
suggests that much of the heterogeneity known to be associated with myeloma 
proteins, and probably also with antibodies  of different specificities may reside 
in the Fd fragment. 
Methods and Materials 
Protein Fraaions.--Normal G immunoglobulins and  G myeloma proteins essentially free 
of IgA and IgM proteins were isolated by starch zone electrophoresis (14). Purity of all frac- 
tions was checked by immunoelectrophoresis. The  "heavy chain" protein Zu was isolated 
from the urine and was kindly supplied by Dr. E. Osserman (15). 
Papain fragments  and polypeptide chains were prepared  as described in reference 16. Fc 
fragments from 3 of 7 type c  (Vi) proteins were difficult to obtain, even when digestion was 
stopped after 1 or 2 hours because they are readily destroyed by the enzyme (17,  18). Con- 
sequently, only 3 Fc fragments of the c  (Vi) type were available for study. 
Fingerprinting was done as described in (13, 16). 
Immunologic studies were performed by double diffusion in agar or by immunoelectrophore- 
sis. The antigenic subtypes of the heavy chains were initially determined by Dr. W. Terry 
and  Dr.  J.  Fahey and,  subsequently  established  in our own laboratory with antisera pre- 
pared against proteins typed by them and  made specific by absorption with myeloma pro- 
reins of the other types. 
More detailed studies of individual variations among myeloma proteins of the We (b)  anti- 
genic subtype were carried out with antisera to 6 of these proteins. These antisera were made 
specific for the heavy chains by absorption with a  pool of Bence Jones proteins of type I 
and II, and failed to react with light chains prepared from the G myeloma protein used for 
immunization. 
RESULTS 
Fig.  1 illustrates a representative peptide map of the Fc fragment from a 
Gm (a+b+f+) subject, and the heavy chain from a normal individual who 
was Gm (a--b+f+). There are about 25 distinct dark spots, and a number of 
fainter ones in the Fc fragment. This is approximately one-half  the number 
expected on the basis of the arginine and lysine content. In addition to these, 
there were 7 to 8 additional dark spots in the heavy chain. On the basis of the 
number of arginlne and lysine residues estimated to be in the Fd fragment (5, 
19), there should have been  almost twice  this number.  In addition, several BIAS  ]~RANGIONE  AND  EDWARD  C.  ]~RANKLIN 
fainter spots were noted. It appeared possible that this discrepancy might be 
due to the heterogeneity of the IgG fraction. If much of the variability in the 
structure  of different antibodies and myeloma proteins were to reside in the 
Fd fragment,  many peptides would be liberated in amounts too small to be 
detected and, consequently, one would expect to see fewer than the calculated 
number of dark peptide spots. In the absence of sufficient amounts of purified 
antibodies  for  analysis,  the  question  was  investigated  by studying  a  large 
number of G myeloma proteins. 
Figs.  2 to 5 compare the fingerprints  of the Fc fragments and heavy chains 
prepared from 2 myelomas of the We (b) type and 2 myeloma proteins of the 
Vi (c) type. The fingerprints  of the Fc fragments of all the myeloma proteins 
belonging  to  the  same  antigenic  subtype were  quite  similar  to  each  other. 
Within Fc fragments of the We type, variations appeared to be related primarily 
to the peptides associated with the Gm types (20). However, 3 of the Fc frag- 
ments of the We type (Ch, Tr, Ma) lacked the peptide shown by the circle in 
Fig. 2, and in 2 others (Bu, De), it was faint and displaced to the fight. Since 
the missing  peptide was present in each of the heavy chains from the same 
protein, it seems possible that this is simply due to technical differences. 
Because of the greater susceptibility of the Fc fragments of the Vi (c) type 
to  proteolysis by papain,  comparative  studies  of  these  fragments  and  the 
heavy chains were possible in only 3 of 7 Vi (c) proteins. The overall appearance 
of these peptide maps (Figs. 4 and 5) was similar to that of the We (b) proteins 
(Figs. 2 and 3). However, in addition to the variations related to the Gm type, 
they had  a  somewhat different arrangement  of some of the peptides at the 
bottom of the map, and generally lacked a peptide in the region  marked by 
the circle.  Since  these differences  were less striking in the heavy chains from 
the same proteins, their precise significance is difficult to evaluate at this time; 
it is possible that  they may be related to the preparative  techniques or the 
greater susceptibility of the fragments to papain digestion.  This problem of the 
variations between different immunologic  and genetic subtypes of 7-chains will 
be discussed more fully in a separate report (21). 
In each instance where fragments were available, comparison of the heavy 
chain  to the Fc fragment  prepared  from the  same myeloma protein clearly 
demonstrated the presence of 6 to 13 extra spots in the heavy chain which were 
not  seen in  the  corresponding  Fc fragments.  The  results  with  14 myeloma 
proteins of the We and Vi types are summarized in Table I.  Detailed com- 
parisons of these peptide maps to each other and  to normal ~,-chains reveal 
three major findings.  Firstly, while  some of these peptides appear in similar 
positions in maps from different ~,-chains,  the overall peptide distribution is 
different for each of the myeloma ~-chains examined,  a finding which suggests 
a unique primary structure for each myeloma protein.  Secondly, from 3 to 9 
spots associated with  the  Fd fragments  of the  myeloma proteins  were also 4  HIF~AN  IM:MUNO  GLOBITLINS 
found in the normal Fd fragments. Since contamination to this extent seems 
unlikely, it seems probable that some of these peptides are present in a signifi- 
cant  fraction  of  normal  G  immunoglobulin  molecules.  Studies  of  the  light 
chains of 8 of the myeloma proteins clearly established that none of the extra 
spots  could be  due  to  the  traces  of light  chain  contaminants  detected by 
immunologic techniques.  Confirmatory evidence localizing more than half of 
the extra spots to the Fd fragment was obtained by studies of the Fab frag- 
ments from nine of the myeloma and a  number of normal proteins. In each 
TABLE I 
Comparison of Peptide Maps of Heavy Chains of 14 Mydoma Proteins to the Homologous Fc 
Fragments and Normal Heavy Chains 
No. of spots in  No. of spots 
Protein  Fd frag. (heavy  No. of spots in 
chain-Fc frag.)  normal Fd frag.  absent from nor-  mal Fd frag. 
We (b) type 
De  ............................. 
Ch  .............................. 
Ma,  .............................. 
Tr .............................. 
Ca  .............................. 
Bu  ............................. 
Ba  ............................. 
Pr  ............................. 
Co  ............................. 
Na  ............................. 
Fr  .............................. 
Vi (c) type 
G1 .............................. 
M~L .............................. 
He  .............................. 
11 
13 
8 
13 
7 
9 
6 
11 
8 
14 
9 
8 
8 
10 
instance, from 5 to 10 of the Fd spots could also be recognized in the maps of 
the Fab fragments. Figs. 6 and 7 illustrate the peptide maps of the Fab frag- 
ments of 2 of the proteins (Pr and He) shown in Figs. 3 and 5. Comparison of 
these  maps  suggests  that most  of the peptides  not contributed by the light 
chains are similar to the peptides attributed to the Fd fragments in the heavy 
chain peptide maps. Thirdly, detailed comparison demonstrated that virtually 
all of the myeloma heavy chains lacked a few (1 to 6) peptides present in normal 
heavy chains, and that they contained others (1 to 7)  which were not detected 
normally. The possible significance of this finding will be discussed below. 
Additional evidence pointing to the association of some of the unique proper- 
ties of myeloma proteins with the respective Fd fragments came from studies BLAS  FRANGIONE  AND  EDWARD  C. FRANKLIN 
TABLE  II 
Localization  on the Fd Fragment  of the Antigenic Specificity  of 3 Mydoma Proteins  of the 
We (b)  Type 
Antiserum to 
Native 
Ma  ..............................  -{- 
Pr ...............................  + 
Fr ................................  I  +  I 
Antigenic Specificity 
Heavy chain 
+ 
+ 
+ 
Fc fragment 
TExT-FIGs.  1 a to 1 d.  Ouchterlony plates using antiserum to a myeloma of type b  (We)- 
Pr in the center wells. 
TExT-Fla.  1 a.  Homologous protein  (Pr)  (top  and  bottom wells)  and  4  other We mye- 
loma proteins in the side wells. 
TEXT-Fro.  1 b.  Homologous Fc fragments  (top  and  bottom wells)  and  Fc fragments  of 
3 other proteins of the same type on the side. The faint outer lines are due to Fab fragment 
contaminants. 
TExT-FIG.  1 c.  Homologous heavy chains  (Pr)  (top  and  bottom wells)  and heavy chain 
of 4 other proteins of the same type on the side. 
TExT-FIG.  1 d.  Fab fragment Pr top and 3 others of the same type laterally. 
of their  antigenic  properties.  Table  II  summarizes  the  results  of immunologic 
analyses  of myeloma  proteins  of  the  We  (b)  type  with  antisera  to  6  of  these 
proteins which had been absorbed  with a  pool of Bence Jones proteins  till they 
no longer reacted  with  light  chains.  The  precipitin  lines of 3  of these  antisera HUMAN  IMMUNOGLOBULINS 
with the homologous protein used for immunization formed significant spurs 
over each of 8 other myeloma proteins of the same antigenic type (Text-fig. 
1 a). In contrast, 3 of the antisera failed to distinguish the proteins used for 
inmmnization. When the  first 3  antisera were  tested with  the  Fc fragments 
from 6 myeloma proteins, including the one used for immunization, they gave a 
reaction  of complete  identity (Text-fig.  1 b).  In  contrast,  the  heavy chains 
used for immunization resembled the native proteins in forming spurs over 4 
other heavy chains (Text-fig. 1 c). Similar studies with the Fab fragments from 
the same proteins showed some degree of antigenic specificity with the frag- 
ment from the  protein used for immunization in  all 5  cases  (Text-fig.  1 d). 
These findings clearly support the concept that some of the antigenic specificity 
of these proteins is also found in the Fd fragment of the heavy chain, but does 
not bear on the question of the antigenic specificity of light chains. 
DISCUSSION 
It is generally accepted that antibodies with different specificities  differ from 
each other in primary structure (22), and that all myeloma proteins, like puri- 
fied antibodies, are structurally unique (23).  Earlier observations of myeloma 
proteins  and  antibodies  emphasized  the  differences in  light  chains  (3,  24). 
More recent studies concerned with the problem of antibody specificity have 
pointed  to  the  role  of  the  heavy chain  in  determining antibody specificity 
(25-29)  and in reflecting differences between different myeloma proteins (5, 9, 
12).  Aside  from  the  starch  gel  electrophoretic  studies  of  myeloma  heavy 
chains by Cohen (5), and the further localization of these differences to the Fd 
fragment by Fahey (9),  little is known about the precise difference between 
different myeloma proteins and antibodies having different specificities. 
The results of the present studies have bearing on several of these points. 
The peptide maps clearly demonstrate  the similarity in  the fingerprints not 
only of the Fc fragments of different myeloma proteins, but also their striking 
resemblance to normal Fc fragments. The observed differences in the maps of 
the heavy chains suggest that the unique peptides must reside in the Fd frag- 
ment,  a  finding consistent  with  the  electrophoretic studies of  Fahey  (9).  A 
more direct test with Fd fragments prepared  by reduction and alkylation of 
Fab pieces, or pepsin digestion of heavy chains has not been possible because of 
our inability to obtain the Fd fragment free of either light chains or large non- 
dializable  peptides.  However,  confirmatory  evidence  was  obtained  by  the 
alternate approach of studying the antigenic properties of the Fab fraction with 
antisera  absorbed  with  light  chains.  Here  again antigenic specificity of the 
protein used for immunization was frequently noted, and shown to reside in the 
Fd fragment. This very limited localization of variability to only one-half of 
what is now considered the heavy chain, taken together with the occurrence in 
man of certain pathologic proteins resembling the Fc fragment (30),  supports BLAS ]~I%ANGIONE AND EDWARD C. ~FRANKLIN 
the possibility that the Fd fragment may be a real structural unit of IgG. This 
concept is further strengthened by some of the results  of genetic studies of 
rabbit "y-globulins (31, 32). 
Of particular interest is the presence, in each of the myeloma heavy chains, 
of a number of peptides not detectable in normal heavy chains, and the absence 
of others characteristic of the normal Fd fragment. This finding lends further 
support to the idea that much of the heterogeneity of normal T-globulin resides 
in differences in the Fd fragments. If this were the case, only those pepfides 
present in a significant fraction of the molecules could be detected, while many 
others present in smaller amounts would not be recognized. This possibility is 
particularly attractive  in view of the many studies suggesting that the  Fd 
fragment is  the region which contains the  antigen-combining sites.  A  more 
definitive answer to this question will have to await the result of similar studies 
with purified antibodies. 
SUMMARy 
1.  Comparison of peptide maps of the Fc fragments of normal G immuno- 
globulins and 11  G myeloma proteins of the We (b)  type showed them to be 
very similar except for differences associated with the  Gm type. Some addi- 
tional differences were noted, however, in the Fc fragments of three Vi  (c) 
myeloma proteins. 
2.  Peptide maps of heavy chains from the same G myeloma proteins differed 
from each other and from normal heavy chains. In general, the myeloma chains 
contained a larger number of well defined spots; some of these were common to 
normal heavy chains while others were unique to each protein. Others, present 
in normal heavy chains, were lacking in the myeloma proteins. 
3.  Comparison of the heavy chains and Fc fragments from the same protein 
suggests that much of the variability of different myeloma proteins and, pre- 
sumably, antibodies resides in the Fd fragment. 
4.  Further support for this is given by the finding that the antigenic speci- 
ficity of 3 myeloma proteins also appeared to reside in the Fd fragments. 
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EXPLANATION OF PLATES 
PI~TE  1 
F~GS. 1 a and 1 b. Pepfide maps of Fc fragment of IgG from a normal Gin (a-t-b+ 
f+)  individual  (Fig.  1 a)  and T-chain from a  normal  Gm  (a-b+f+)  individual 
(Fig. 1 b). The circle marks the Gm (a) spot. 
Fx6s. 2 a and 2 b. Peptide maps of Fc fragment (Fig. 2 a) and T-chain from a  Gm 
(a-k)  G myeloma (Ch)  of type b  (We)  (Fig. 2 b).  The peptide marked by circle  is 
faint in the Fc fragment. THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL.  122  PLATE  1 
(Frangione and Franklin: Human immunoglobulins) PLATE  2 
FIGS. 3 a  and 3 b. Peptide maps of Fc fragment (Fig. 3 a) and "),-chain from a  Gm 
(f+)  G myeloma (Pr) of type b  (We)  (Fig. 3 b). 
Fins. 4  a  and 4  b.  Peptide maps of Fc fragment  (Fig. 4  a)  and "y-chain  of a  Gm 
(b +)  G myeloma (G1) of type c (Vi) (Fig. 4 b). The arrow points to some of the pep- 
tide differences at the bottom. The circle marks the region of the missing peptide. THE  JOURNAL  OF EXPERIMENTAL  MEDICINE  VOL. 122  PLATE  2 
(Frangione and Franklin: Human immunoglobulins) PLATE 3 
FIGS. 5 a  and 5 b. Peptide maps of Fc fragment (Fig. 5 a)  and 3,-chain of a  Gm 
(b +)  G myeloma (He)  of type c (Vi)  (Fig.  5 b). The circle marks a peptide lacking 
in the Fc fragment of this protein. The arrow points to 3 peptides which are prominent 
in about 20 per cent of normal IgG fractions. Here, too,  there are some peptide dif- 
ferences  at the bottom similar to those in Figs. 4 a and 4 b. 
FIG. 6. Peptide map of the Fab fragment of Pr (Figs. 3 a and 3 b). The spots with a 
circle are contributed by the Fd fragments. 
FIG. 7. Peptide map of the Fab fragment of He (Figs. 5 a and 5 b). The spots with 
a circle  are contributed by the Fd fragments. THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL.  122  PLATE 3 
(Frangione and Franklin: Human immunoglobulins) 